First of all, thank you for inviting me to speak to the committee.
I'm an epidemiologist. My research in this area typically focuses on addictions and injury prevention. I have a particular focus on road safety and traffic safety.
I'm going to speak to the issue of drug-impaired driving, in particular the role of cannabis. I also have some other interests as well. Some of my research is focused on issues around youth, trends in youth consumption, young adult consumption, this notion of normalization of cannabis and some of the issues about how we define problematic or harmful use. I will speak on these if time permits, and please cut me off, because I can ramble on.
It's important when we're talking about these issues in terms of the health risks related to cannabis to contextualize how cannabis is used or the nature of the use. It's important to think about cannabis in some of the same ways we think about alcohol. Not much of the harm associated with cannabis is linked to what we would call uncontrolled or irresponsible consumption, and where the potential for harm is maximized relative to more controlled use where harm is minimal or non-existent. I want to speak to these issues when I cover these topics.
In terms of cannabis and driving, there are three or four key points that I want to get across around the issue. We know from the experimental research that cannabis, when it's consumed in sufficient quantities, impairs the cognitive and psychomotor skills that are necessary for the safe driving of a motor vehicle. This has come out of an extensive experimental set of studies. Many of the aspects of driving are impaired, including things like vehicle tracking, reaction time, attention, and so on and so forth. This is important because we know from both hospital data and from survey data that rates of driving under the influence of cannabis have been rising in the last 20 years.
Depending on the survey, self-reported rates of driving under the influence of cannabis range from one in ten to four in ten youth, depending on the jurisdiction, who use cannabis and drive within one to two hours. That's an important threshold, the one to two hours, because you're going to see the impacts of THC on impairments on driving performance is going to be within that narrow threshold of time.
We also know from administrative hospital data that between 10% to 20% of drivers in crashes—these are individuals in crashes who are presented to hospital with an injury—test positive for THC. We also know that about 6% of drivers randomly stopped in the recent B.C. roadside survey tested positive for THC. Data from Transport Canada noted that a high proportion of fatally injured drivers also tested positive for THC. In many of these cases, it's polydrug use as well, but THC is present.
Finally, a lot of the surveys, particularly among youth and young adults, that have come out of Australia, the U.S., and Canada, indicate that self-reported rates of driving under the influence of cannabis actually have surpassed rates of drinking and driving. They are higher. This is an area potentially of concern.
The important thing is, from a road safety perspective, how does the consumption of cannabis prior to driving affect the likelihood of being in a crash or an accident? We know that recent or acute use, again, within an hour or two before driving increases the risk of a crash about twofold. That's generally been supported in a number of med analyses, which are systematic reviews which are high level summaries of the evidence that's out there. That has been confirmed when you measure cannabis in blood.
The key aspect is to objectively measure recent use. The finding is less clear when it's measured in urine, when you do an analysis of the presence of THC. That's largely a result of some of the inconsistencies in measuring the exact timing of consumption relative to the driving event.
The association of cannabis with crash rates also is typically stronger when you look at more severe crashes involving injury or death. The evidence is not so clear when you look at less severe crashes or non-injury crashes.
There also appears to be a dose-response relationship so that the crash risk is increased at higher levels of THC that are measured in blood, and that there are strong synergistic effects with alcohol even at thresholds below those at which each drug would independently impair someone.
This is a really important issue, but there are still some discrepancies in the findings. A lot of that has to do with our inability to have the most perfect studies, for lack of a better word, to study the issue.
It's really a challenge to study this issue, because in order to appropriately assess whether cannabis increases the risk of a crash requires taking samples from individuals not only in crashes, but individuals who were not in crashes. That's an extremely challenging issue from a research ethical perspective and logistical perspective: how do we stop people on the roadside and get them to give us blood tests so that we can measure cannabis in the roadside population relative to those involved in crashes? That's a challenging issue. More work needs to be done in this particular area. We need some high-quality studies and studies that measure THC in blood, not urine, and that measure THC, again, in these control samples.
In terms of the legislation, you've probably heard from expert witnesses on the topic around the current state of legislation for cannabis and driving in Canada. There are varying policies across the globe around how we detect and determine impairment. These policies vary in how cannabis drivers are detected, the methods that are employed to determine their legal impairment, and then the associated punishment, whether it's a criminal charge or administrative sanction.
Detection typically takes two forms. One is through an observation of driver impairment while behind the wheel. You probably have grounds that a driver is driving erratically and may be impaired, and therefore you stop them. That's what we use in Canada. You have the probable grounds that they're driving erratically and you pull them over. In other countries, they'll do random stops or spot checks, and assess without specific cause.
When you determine impairment, in Canada we have, as you probably heard, the drug recognition expert program, where we detect impairment through a series of 12 stages. First is to look for alcohol impairment, and then move on to other drugs. Other countries set zero tolerance levels, where any amount of THC present in the body is indication of impairment. That has some problems, because of the way you measure THC. If you measure it in blood, it's a little bit better, but most of the time it's in urine, and that's not so good, because it could include use that happened weeks prior. Other countries have per se limits like we do for alcohol, where you have 80 milligrams per cent for alcohol as a Criminal Code sanction. There have been suggestions of what that should be set at. Some places have a range in the 5 nanograms a microlitre, or 7 nanograms to 10 nanograms a microlitre, which would be equivalent to about a 50 milligram per cent for blood alcohol content. These are different examples.
We don't have very good roadside testing technologies. We don't have a breathalyzer for cannabis. There is some testing that's going on in Australia, for instance, using saliva tests, using saliva strips, but they have their own problems. These oral fluid tests have problems in terms of false positives and false negatives, so the jury is still out on that particular issue.
Do I have another couple of minutes?